 | • レポートコード：MRC2-11QY10932 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自己マトリックス誘導軟骨形成（AMIC）のグローバル市場について調査・分析したレポートです。種類別（ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-co-グリコール酸（PGLA）、その他）市場規模、用途別（膝軟骨修復、股関節軟骨修復、肘軟骨修復、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自己マトリックス誘導軟骨形成（AMIC）の競争状況、市場シェア ・世界の自己マトリックス誘導軟骨形成（AMIC）市場：種類別市場規模 2015年-2020年（ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-co-グリコール酸（PGLA）、その他） ・世界の自己マトリックス誘導軟骨形成（AMIC）市場：種類別市場規模予測 2021年-2026年（ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-co-グリコール酸（PGLA）、その他） ・世界の自己マトリックス誘導軟骨形成（AMIC）市場：用途別市場規模 2015年-2020年（膝軟骨修復、股関節軟骨修復、肘軟骨修復、その他） ・世界の自己マトリックス誘導軟骨形成（AMIC）市場：用途別市場規模予測 2021年-2026年（膝軟骨修復、股関節軟骨修復、肘軟骨修復、その他） ・北米の自己マトリックス誘導軟骨形成（AMIC）市場分析：米国、カナダ ・ヨーロッパの自己マトリックス誘導軟骨形成（AMIC）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自己マトリックス誘導軟骨形成（AMIC）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自己マトリックス誘導軟骨形成（AMIC）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自己マトリックス誘導軟骨形成（AMIC）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Anika Therapeutics, Inc.、Arthro-Kinetics、B. Braun Melsungen AG、BioTissue AG、CartiHeal、Geistlich Pharma AG、JRI Orthopaedics Ltd.、Matricel GmbH、Smith & Nephew plc、Zimmer Biomet Holdings ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market
The global Autologous Matrix-Induced Chondrogenesis (AMIC) market size is projected to reach US$ 107.1 million by 2026, from US$ 101.7 million in 2020, at a CAGR of 4.9%% during 2021-2026.
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Scope and Market Size
Autologous Matrix-Induced Chondrogenesis (AMIC) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autologous Matrix-Induced Chondrogenesis (AMIC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Anika Therapeutics, Inc.
Arthro-Kinetics
B. Braun Melsungen AG
BioTissue AG
CartiHeal
Geistlich Pharma AG
JRI Orthopaedics Ltd.
Matricel GmbH
Smith & Nephew plc
Zimmer Biomet Holdings
Market segment by Type, the product can be split into
Hyaluronic Acid
Collagen
Polyethylene glycol (PEG)
polylactic-co-glycolic acid (PGLA)
Others
Market segment by Application, split into
Knee Cartilage Repair
Hip Cartilage Repair
Elbow Cartilage Repair
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue
1.4 Market by Type
1.4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hyaluronic Acid
1.4.3 Collagen
1.4.4 Polyethylene glycol (PEG)
1.4.5 polylactic-co-glycolic acid (PGLA)
1.4.6 Others
1.5 Market by Application
1.5.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application: 2020 VS 2026
1.5.2 Knee Cartilage Repair
1.5.3 Hip Cartilage Repair
1.5.4 Elbow Cartilage Repair
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Perspective (2015-2026)
2.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Growth Trends by Regions
2.2.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Share by Regions (2015-2020)
2.2.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Strategy
2.3.6 Primary Interviews with Key Autologous Matrix-Induced Chondrogenesis (AMIC) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Market Size
3.1.1 Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Revenue (2015-2020)
3.1.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Players (2015-2020)
3.1.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Concentration Ratio
3.2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in 2019
3.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players Head office and Area Served
3.4 Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Product Solution and Service
3.5 Date of Enter into Autologous Matrix-Induced Chondrogenesis (AMIC) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Size by Type (2015-2020)
4.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
5.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
6.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in North America (2019-2020)
6.3 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
6.4 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
7.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in Europe (2019-2020)
7.3 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
7.4 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
8 China
8.1 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
8.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in China (2019-2020)
8.3 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
8.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
9.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in Japan (2019-2020)
9.3 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
9.4 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
10.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
10.4 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
11 India
11.1 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
11.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in India (2019-2020)
11.3 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
11.4 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2015-2020)
12.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players in Central & South America (2019-2020)
12.3 Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020)
12.4 Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Anika Therapeutics, Inc.
13.1.1 Anika Therapeutics, Inc. Company Details
13.1.2 Anika Therapeutics, Inc. Business Overview
13.1.3 Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.1.4 Anika Therapeutics, Inc. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020))
13.1.5 Anika Therapeutics, Inc. Recent Development
13.2 Arthro-Kinetics
13.2.1 Arthro-Kinetics Company Details
13.2.2 Arthro-Kinetics Business Overview
13.2.3 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.2.4 Arthro-Kinetics Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.2.5 Arthro-Kinetics Recent Development
13.3 B. Braun Melsungen AG
13.3.1 B. Braun Melsungen AG Company Details
13.3.2 B. Braun Melsungen AG Business Overview
13.3.3 B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.3.4 B. Braun Melsungen AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.3.5 B. Braun Melsungen AG Recent Development
13.4 BioTissue AG
13.4.1 BioTissue AG Company Details
13.4.2 BioTissue AG Business Overview
13.4.3 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.4.4 BioTissue AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.4.5 BioTissue AG Recent Development
13.5 CartiHeal
13.5.1 CartiHeal Company Details
13.5.2 CartiHeal Business Overview
13.5.3 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.5.4 CartiHeal Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.5.5 CartiHeal Recent Development
13.6 Geistlich Pharma AG
13.6.1 Geistlich Pharma AG Company Details
13.6.2 Geistlich Pharma AG Business Overview
13.6.3 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.6.4 Geistlich Pharma AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.6.5 Geistlich Pharma AG Recent Development
13.7 JRI Orthopaedics Ltd.
13.7.1 JRI Orthopaedics Ltd. Company Details
13.7.2 JRI Orthopaedics Ltd. Business Overview
13.7.3 JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.7.4 JRI Orthopaedics Ltd. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.7.5 JRI Orthopaedics Ltd. Recent Development
13.8 Matricel GmbH
13.8.1 Matricel GmbH Company Details
13.8.2 Matricel GmbH Business Overview
13.8.3 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.8.4 Matricel GmbH Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.8.5 Matricel GmbH Recent Development
13.9 Smith & Nephew plc
13.9.1 Smith & Nephew plc Company Details
13.9.2 Smith & Nephew plc Business Overview
13.9.3 Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.9.4 Smith & Nephew plc Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.9.5 Smith & Nephew plc Recent Development
13.10 Zimmer Biomet Holdings
13.10.1 Zimmer Biomet Holdings Company Details
13.10.2 Zimmer Biomet Holdings Business Overview
13.10.3 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
13.10.4 Zimmer Biomet Holdings Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020)
13.10.5 Zimmer Biomet Holdings Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Autologous Matrix-Induced Chondrogenesis (AMIC) Key Market Segments
Table 2. Key Players Covered: Ranking by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue
Table 3. Ranking of Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hyaluronic Acid
Table 6. Key Players of Collagen
Table 7. Key Players of Polyethylene glycol (PEG)
Table 8. Key Players of polylactic-co-glycolic acid (PGLA)
Table 9. Key Players of Others
Table 10. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Regions (2015-2020)
Table 14. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Strategy
Table 20. Main Points Interviewed from Key Autologous Matrix-Induced Chondrogenesis (AMIC) Players
Table 21. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Players (2015-2020) (Million US$)
Table 22. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Players (2015-2020)
Table 23. Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) as of 2019)
Table 24. Global Autologous Matrix-Induced Chondrogenesis (AMIC) by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Product Solution and Service
Table 27. Date of Enter into Autologous Matrix-Induced Chondrogenesis (AMIC) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type (2015-2020)
Table 31. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Type (2021-2026)
Table 32. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Application (2015-2020)
Table 33. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 37. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 39. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 41. Europe Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 43. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 45. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 47. China Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 48. China Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 49. China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 50. China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 51. China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 52. China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 53. Japan Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 55. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 57. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 61. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 63. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 65. India Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 66. India Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 67. India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 68. India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 69. India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 70. India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (2019-2020)
Table 73. Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type (2015-2020)
Table 75. Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application (2015-2020)
Table 77. Anika Therapeutics, Inc. Company Details
Table 78. Anika Therapeutics, Inc. Business Overview
Table 79. Anika Therapeutics, Inc. Product
Table 80. Anika Therapeutics, Inc. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 81. Anika Therapeutics, Inc. Recent Development
Table 82. Arthro-Kinetics Company Details
Table 83. Arthro-Kinetics Business Overview
Table 84. Arthro-Kinetics Product
Table 85. Arthro-Kinetics Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 86. Arthro-Kinetics Recent Development
Table 87. B. Braun Melsungen AG Company Details
Table 88. B. Braun Melsungen AG Business Overview
Table 89. B. Braun Melsungen AG Product
Table 90. B. Braun Melsungen AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 91. B. Braun Melsungen AG Recent Development
Table 92. BioTissue AG Company Details
Table 93. BioTissue AG Business Overview
Table 94. BioTissue AG Product
Table 95. BioTissue AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 96. BioTissue AG Recent Development
Table 97. CartiHeal Company Details
Table 98. CartiHeal Business Overview
Table 99. CartiHeal Product
Table 100. CartiHeal Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 101. CartiHeal Recent Development
Table 102. Geistlich Pharma AG Company Details
Table 103. Geistlich Pharma AG Business Overview
Table 104. Geistlich Pharma AG Product
Table 105. Geistlich Pharma AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 106. Geistlich Pharma AG Recent Development
Table 107. JRI Orthopaedics Ltd. Company Details
Table 108. JRI Orthopaedics Ltd. Business Overview
Table 109. JRI Orthopaedics Ltd. Product
Table 110. JRI Orthopaedics Ltd. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 111. JRI Orthopaedics Ltd. Recent Development
Table 112. Matricel GmbH Business Overview
Table 113. Matricel GmbH Product
Table 114. Matricel GmbH Company Details
Table 115. Matricel GmbH Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 116. Matricel GmbH Recent Development
Table 117. Smith & Nephew plc Company Details
Table 118. Smith & Nephew plc Business Overview
Table 119. Smith & Nephew plc Product
Table 120. Smith & Nephew plc Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 121. Smith & Nephew plc Recent Development
Table 122. Zimmer Biomet Holdings Company Details
Table 123. Zimmer Biomet Holdings Business Overview
Table 124. Zimmer Biomet Holdings Product
Table 125. Zimmer Biomet Holdings Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2015-2020) (Million US$)
Table 126. Zimmer Biomet Holdings Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type: 2020 VS 2026
Figure 2. Hyaluronic Acid Features
Figure 3. Collagen Features
Figure 4. Polyethylene glycol (PEG) Features
Figure 5. polylactic-co-glycolic acid (PGLA) Features
Figure 6. Others Features
Figure 7. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application: 2020 VS 2026
Figure 8. Knee Cartilage Repair Case Studies
Figure 9. Hip Cartilage Repair Case Studies
Figure 10. Elbow Cartilage Repair Case Studies
Figure 11. Others Case Studies
Figure 12. Autologous Matrix-Induced Chondrogenesis (AMIC) Report Years Considered
Figure 13. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Regions: 2020 VS 2026
Figure 15. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Players in 2019
Figure 18. Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in 2019
Figure 20. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
自家幹細胞ベース治療法の世界市場（～2026年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autologous Stem Cell Based Therapies Scop…- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- オピオイド誘発性便秘（OIC）治療の世界市場（～2026年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid-Induced Constipation…
- 化学療法誘発性悪心・嘔吐（CINV）の世界市場（～2026年） Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides…